Adenovirus COVID-19 Vaccines: Challenges of Prior AD Immunity
Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.
Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.
Dr. Soon-Shiong delves into some of his reasoning for the ImmunityBio vaccine candidate's particular orientation toward the immune system.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Recent Videos
Federal Government Changes Course Again on COVID-19 Vaccine Policy
Clinicians Discuss the State of Vaccines Today
How Will the New FDA COVID-19 Vaccine Policy Affect the Pediatric Population?
Maternal RSV Vaccines Show Promise for Infant Protection but Raise Safety Concerns
High Vaccine Acceptance in Sierra Leone Highlights Role of Trust, Messaging, and Misinformation
Handwashing: An Infection Prevention Method That We Forget?
Pertussis: Another Vaccine-Preventable Disease Seeing a Major Resurgence
When Will the Measles Outbreak End?
Has Measles Become a Binary Choice Between Trying to Treat the Disease Vs Prevention?
Novavax vs mRNA Vaccines: Understanding Vaccine Reactogenicity
Related Content
